More About Bryan
Bryan is an investing analyst on the Bio + Health team, focused on life science investment opportunities.
Prior to joining Andreessen Horowitz, he spent time as an investment fellow at 5AM Ventures while completing his PhD in Biophysics at the University of California, San Francisco (UCSF). At UCSF, Bryan studied the various ways antibodies can manipulate protein conformation in pathology and for therapeutic pharmacology and separately defined signaling-selective mechanisms of G protein-coupled receptor activity. His work has been published in Nature, Science, and Cell. He has also held R&D roles in protein chemistry and antibody biophysics at Genentech and Abbvie Stemcentrx, respectively.
When not thinking about proteins, Bryan can be found on a surfboard, in the kitchen roasting coffee, or in search of the perfect tacos al pastor.
